<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Harvard Gazette</provider_name><provider_url>https://dev.news.harvard.edu/gazette</provider_url><author_name>harvardgazette</author_name><author_url>https://dev.news.harvard.edu/gazette/story/author/harvardgazette/</author_url><title>Antibody halts cancer-related wasting condition &#x2014; Harvard Gazette</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="pCf4X0glQr"&gt;&lt;a href="https://dev.news.harvard.edu/gazette/story/2014/07/antibody-halts-cancer-related-wasting-condition/"&gt;Antibody halts cancer-related wasting condition&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://dev.news.harvard.edu/gazette/story/2014/07/antibody-halts-cancer-related-wasting-condition/embed/#?secret=pCf4X0glQr" width="600" height="338" title="&#x201C;Antibody halts cancer-related wasting condition&#x201D; &#x2014; Harvard Gazette" data-secret="pCf4X0glQr" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://dev.news.harvard.edu/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://dev.news.harvard.edu/wp-content/uploads/2014/07/spiegleman605.jpg</thumbnail_url><thumbnail_width>605</thumbnail_width><thumbnail_height>403</thumbnail_height><description>New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle that occurs in about half of all cancer patients, increasing their risk of death. Harvard Professor Bruce Spiegelman demonstrated that symptoms of cachexia in mice improved when given an antibody that blocked the effects of a protein secreted by the tumor cells.</description></oembed>
